Patient Product Information

Patients should read this information before they start taking a product and each time they refill their prescription, in case any information has changed. This provides only a summary of certain information about the product. It does not take the place of careful discussions between patients and their doctors.      COSOPT® (dorzolamide hydrochloride-timolol maleate ophthalmic solution)       COZAAR® (losartan potassium tablets)      (See Boxed Warning on use in pregnancy in Prescribing Information)      CRIXIVAN® (indinavir sulfate)       EMEND® (aprepitant)       FOSAMAX® (alendronate sodium)  (once Daily)      FOSAMAX® (alendronate sodium)  (once Weekly)      FOSAMAX PLUS D™ (alendronate sodium/cholecalciferol)       HYZAAR® (losartan potassium-hydrochlorothiazide tablets)      (See Boxed Warning on use in pregnancy in Prescribing Information)      JANUMET™ (sitagliptin/metformin HCl) tablets     (Please read the Boxed Warning about lactic acidosis in the Prescribing Information.)      JANUVIA™ (sitagliptin) tablets      MAXALT® (rizatriptan benzoate) Tablets MAXALT-MLT® (rizatriptan benzoate) Orally Disintegrating Tablets      PROPECIA® (finasteride)       PROSCAR® (finasteride)       SINGULAIR® (montelukast sodium)       ZOLINZA® (vorinostat) Capsules Merck/Schering-Plough Pharmaceuticals      VYTORIN® (ezetimibe/simvastatin) Tablets      ZETIA® (ezetimibe) Tablets

Viewing files designated with requires a PDF reader

COZAAR and HYZAAR are registered trademarks of E.I. du Pont de Nemours and Company, Wilmington, Delaware, USA
FOSAMAX PLUS D is a trademark of Merck & Co., Inc.
VYTORIN and ZETIA are registered trademarks of MSP Singapore Company, LLC. View the Merck/Schering-Plough privacy policy.
All other brand names are registered trademarks of Merck & Co., Inc.
MerckServices and MerckSource are registered trademarks of Merck & Co., Inc.
MerckProductServices and MerckMedicus are trademarks of Merck & Co., Inc.